Jeff Reeves’s Strength in Numbers: 5 reasons to bank on biotech stocks now | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 5 February, 2017 by The TZ Newswire Staff

Jeff Reeves’s Strength in Numbers: 5 reasons to bank on biotech stocks now

Start with valuations look reasonable, buyouts are likely and you shouldn’t sweat Donald Trump’s rhetoric, says Jeff Reeves.
read more

See also
- Next Article What to Watch When Disney Reports Earnings
- Previous Article Mark Hulbert: Expect even more good news about Apple
Editorial Calender

February 2017

M T W T F S S

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28

« Jan Mar »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar